KOBE UNIVERSITY

Kobe University bioengineers engineered yeast to produce artepillin C, a plant-derived compound with health benefits, at unprecedented concentrations, paving the way for microbial production of other plant-derived compounds.

NSF funding supports Imperial's Global Center for Biofoundry Applications, aiming to develop standards and metrics for biofoundries to accelerate the global bioeconomy, addressing challenges like climate change and food security.

Akihiko Kondo at Kobe University emphasizes the role of biofoundry in expediting synthetic biology development. The Ministry of Science and ICT plans to announce a specialized research institute for bio-foundry R&D. Pimchai Chaiyan discusses using discarded organic matter for carbon neutrality through bioconversion.

Kobe University-led research finds low-dose aspirin or heparin treatment effective in preventing pregnancy loss or complications in women with self-targeting antibodies, with 87% live births in treated group vs. 50% in untreated, and complications reduced from 50% to 6%.